GO:0015538 sialic acid:proton symporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015538 describes a secondary active transport activity that couples the inward movement of sialic acid to the inward movement of protons across a membrane.
• The best-characterized protein carrying this activity is Sialin (SLC17A5), a lysosomal transporter that exports sialic acid from lysosomes in a proton-dependent manner.
• Loss-of-function mutations in SLC17A5 cause sialic acid storage diseases, including Salla disease and infantile free sialic acid storage disease, which are characterized by lysosomal accumulation of free sialic acid.
• The transport activity is driven by the lysosomal proton gradient generated by vacuolar H+-ATPases, which acidify the lysosomal lumen.
• Experimental evidence from lysosomal membrane vesicles and purified transporter preparations demonstrates that sialic acid uptake is proton-dependent and can be inhibited by other acidic monosaccharides.
• Studying GO:0015538 requires a combination of transport assays, lysosomal pH measurements, and genetic models such as SLC17A5 knockout or point-mutant cell lines.
Description
Sialic acid:proton symporter activity (GO:0015538) is a molecular function that enables the coupled transport of sialic acid and protons across a biological membrane. This activity is essential for maintaining the proper distribution of sialic acid within cells, particularly in lysosomes, where sialic acid must be exported to prevent its accumulation. The transporter responsible for this activity in humans is Sialin (encoded by SLC17A5), a member of the solute carrier family 17. Researchers study GO:0015538 to understand lysosomal storage disorders, sialic acid metabolism, and the broader principles of secondary active transport. The activity is also relevant to neurobiology, as sialic acid storage diseases often present with severe neurological impairment.
sialic acid:proton symporter activity At A Glance
| GO ID | GO:0015538 |
|---|---|
| GO term | sialic acid:proton symporter activity |
| Ontology | molecular_function |
| Synonym | sialic acid:hydrogen symporter activity; sialic acid permease activity |
| Definition | Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: sialate(out) + H+(out) = sialate(in) + H+(in). |
| Major function | Proton-coupled transport of sialic acid across cellular membranes, particularly the lysosomal membrane. |
| Representative protein | Sialin (SLC17A5) in humans. |
| Associated disease | Sialic acid storage diseases (Salla disease, infantile free sialic acid storage disease). |
| Cellular location | Lysosomal membrane. |
What Is GO:0015538?
According to the Gene Ontology, GO:0015538 enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: sialate(out) + H+(out) = sialate(in) + H+(in). In other words, it is a symport activity that couples the movement of sialic acid (an acidic monosaccharide) with the movement of protons in the same direction across a membrane. This definition is based on the QuickGO entry for GO:0015538.
Why Is sialic acid:proton symporter activity Important in Cell Biology?
GO:0015538 is critical for lysosomal homeostasis and sialic acid metabolism. Defects in this activity lead to sialic acid storage diseases, a group of rare inherited disorders with severe neurological consequences. Understanding the molecular mechanism of this symporter provides insights into secondary active transport, lysosomal biology, and potential therapeutic targets for lysosomal storage disorders.
• Maintains lysosomal sialic acid homeostasis by exporting free sialic acid from the lysosomal lumen.
• Mutations in SLC17A5, the gene encoding the sialic acid:proton symporter, cause Salla disease and infantile free sialic acid storage disease.
• Provides a model system for studying proton-coupled secondary active transport.
• Contributes to the understanding of lysosomal membrane transport defects in neurodegenerative disorders.
• Relevant to cancer biology, as altered sialic acid metabolism affects cell surface sialylation and tumor progression.
• Potential target for pharmacological chaperones or substrate reduction therapies in sialic acid storage diseases.
• Involved in the broader family of monocarboxylate transporters, sharing functional characteristics.
• Essential for normal brain development, as sialic acid is a key component of gangliosides and glycoproteins.
What Happens During sialic acid:proton symporter activity?
Proton Gradient Generation
In simple terms: The cell creates an acidic environment inside lysosomes by pumping protons in.
The vacuolar H+-ATPase (V-ATPase) hydrolyzes ATP to pump protons into the lysosomal lumen, establishing a proton gradient (pH ~4.5-5.0) and a membrane potential. This gradient provides the driving force for secondary active transport of sialic acid.
Substrate Recognition and Binding
In simple terms: The transporter recognizes sialic acid and a proton on the outside of the lysosome.
The sialic acid:proton symporter, Sialin, binds sialic acid and a proton from the lysosomal lumen. The transporter exhibits specificity for acidic monosaccharides, including sialic acid, glucuronic acid, and iduronic acid.
Coupled Translocation
In simple terms: The transporter moves both sialic acid and a proton together across the membrane.
Upon binding, the transporter undergoes a conformational change that translocates both sialic acid and the proton to the cytoplasmic side of the lysosomal membrane. This symport mechanism ensures that the transport of sialic acid is tightly coupled to proton movement.
Substrate Release and Reset
In simple terms: Sialic acid and the proton are released into the cytoplasm, and the transporter resets.
After releasing sialic acid and the proton into the cytoplasm, the transporter returns to its original conformation, ready for another cycle. The proton is released into the cytosol, where the pH is higher, completing the cycle.
Key Genes Involved in GO:0015538 sialic acid:proton symporter activity
The following genes and proteins are directly or indirectly involved in sialic acid:proton symporter activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC17A5 | Encodes Sialin, the lysosomal sialic acid:proton symporter | Mutations cause sialic acid storage diseases; key target for functional studies. |
| ATP6V0A1 | Component of V-ATPase, generates proton gradient | Provides driving force for sialic acid transport; knockout affects lysosomal pH. |
| ATP6V1B1 | V-ATPase subunit | Regulates lysosomal acidification; potential modifier of transport activity. |
| GLB1 | Beta-galactosidase, involved in sialic acid metabolism | Defects lead to GM1 gangliosidosis; may affect sialic acid levels. |
| NEU1 | Sialidase, removes sialic acid from glycoconjugates | Regulates free sialic acid availability in lysosomes. |
| GNE | UDP-GlcNAc 2-epimerase/ManNAc kinase, sialic acid biosynthesis | Influences cellular sialic acid levels; mutations cause GNE myopathy. |
| SLC17A3 | Related solute carrier, urate transporter | Shares homology with SLC17A5; used in comparative studies. |
| SLC17A1 | Sodium-dependent phosphate transporter | Member of SLC17 family; provides evolutionary context. |
| SLC17A2 | Solute carrier family 17 member 2 | Related transporter; potential functional redundancy. |
| SLC17A4 | Solute carrier family 17 member 4 | Expressed in intestine; may transport sialic acid. |
| CTNS | Cystinosin, lysosomal cystine transporter | Mutations cause cystinosis; shares transport defects with sialic acid storage. |
| LAMP1 | Lysosomal-associated membrane protein 1 | Marker for lysosomal membrane; used in co-localization studies. |
| LAMP2 | Lysosomal-associated membrane protein 2 | Marker for lysosomes; helps assess transporter localization. |
| TFEB | Transcription factor EB, master regulator of lysosomal biogenesis | Regulates expression of lysosomal genes including SLC17A5. |
| mTORC1 | Kinase complex that inhibits TFEB | Regulates lysosomal function and indirectly sialic acid transport. |
| VPS35 | Retromer component, involved in lysosomal protein sorting | May affect Sialin trafficking to lysosomes. |
| CLN3 | Lysosomal transmembrane protein | Mutations cause Batten disease; may interact with sialic acid metabolism. |
How Is sialic acid:proton symporter activity Regulated?
The activity of the sialic acid:proton symporter is primarily regulated by the lysosomal proton gradient, which is maintained by the V-ATPase. Additionally, the transcription factor TFEB controls the expression of many lysosomal genes, including SLC17A5, and is inhibited by mTORC1 under nutrient-rich conditions. Thus, nutrient status can indirectly regulate sialic acid transport capacity. Furthermore, the transporter may be subject to post-translational modifications, although specific regulatory mechanisms remain to be fully elucidated.
sialic acid:proton symporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC17A5 | Salla disease; infantile free sialic acid storage disease | Patient-derived fibroblasts; SLC17A5 knockout HeLa cells. |
| SLC17A5 | Non-syndromic intellectual disability | Induced pluripotent stem cell-derived neurons from patients. |
| CTNS | Cystinosis; lysosomal transport defect | CTNS knockout cell lines; transport assays. |
| GNE | GNE myopathy; sialic acid biosynthesis defect | GNE knockout HEK293 cells; sialic acid supplementation studies. |
| ATP6V0A1 | Lysosomal acidification disorders | ATP6V0A1 knockout cells; pH measurements. |
Sialic Acid Storage Diseases
Biallelic mutations in SLC17A5 cause sialic acid storage diseases, a spectrum of disorders ranging from mild Salla disease to severe infantile free sialic acid storage disease. These mutations impair the transport activity of Sialin, leading to lysosomal accumulation of free sialic acid and excretion in urine. Patients present with neurological symptoms including hypotonia, ataxia, and intellectual disability.
Neurodegeneration and Intellectual Disability
Defects in sialic acid:proton symporter activity have been linked to non-syndromic intellectual disability in a large Swedish family, where exome analysis implicated multiple genes including SLC17A5. The accumulation of sialic acid in lysosomes can lead to neuronal dysfunction and neurodegeneration, highlighting the importance of this transport activity for brain health.
Cancer and Altered Sialylation
Altered sialic acid metabolism is a hallmark of cancer, affecting cell surface sialylation, cell adhesion, and immune evasion. While direct mutations in SLC17A5 are not common in cancer, changes in lysosomal sialic acid transport can influence the availability of sialic acid for glycosylation pathways, potentially impacting tumor progression.
From sialic acid:proton symporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC17A5 impair sialic acid export? | SLC17A5 knockout HeLa or HEK293 cells. |
| What is the effect of a specific point mutation on transport activity? | Point-mutant SLC17A5 knock-in cell lines. |
| Can wild-type SLC17A5 rescue the transport defect? | Overexpression of SLC17A5 in patient fibroblasts. |
| Where is Sialin localized within the cell? | Tagged knock-in of SLC17A5 with GFP or FLAG. |
| How does lysosomal pH affect transport? | Cells treated with V-ATPase inhibitors; pH-sensitive dyes. |
| What genes modify the sialic acid storage phenotype? | CRISPR library screening in SLC17A5 knockout cells. |
How to Study the sialic acid:proton symporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive sialic acid uptake | Transport activity in isolated lysosomes | Functional characterization of Sialin mutants. |
| LysoSensor staining | Lysosomal pH | Assessment of V-ATPase function. |
| Immunofluorescence | Subcellular localization of Sialin | Co-localization with lysosomal markers. |
| Co-immunoprecipitation | Protein-protein interactions | Identification of Sialin binding partners. |
| CRISPR knockout screening | Genes required for sialic acid homeostasis | Discovery of modifiers of storage diseases. |
| Exome sequencing | Mutations in SLC17A5 and other genes | Diagnosis of sialic acid storage diseases. |
| Proteoliposome reconstitution | Intrinsic transport activity | Biochemical characterization of purified Sialin. |
| qPCR | mRNA expression levels | Evaluation of SLC17A5 expression in disease models. |
Transport Assays
Radioactive or fluorescent sialic acid uptake assays using isolated lysosomes or proteoliposomes reconstituted with purified Sialin can directly measure transport activity. These assays are performed in the presence of a proton gradient to mimic physiological conditions.
Lysosomal pH Measurements
Lysosomal pH can be measured using ratiometric fluorescent dyes such as LysoSensor or pHluorin-tagged lysosomal proteins. This is crucial because the proton gradient drives sialic acid transport.
Proteomics and Interaction Studies
Co-immunoprecipitation and mass spectrometry can identify proteins interacting with Sialin, revealing potential regulatory partners. Proximity labeling techniques such as BioID can map the Sialin interactome in living cells.
Genetic and Genomic Approaches
CRISPR-Cas9 knockout screens, RNA interference, and exome sequencing can identify genes that modify sialic acid transport or cause storage diseases. Transcriptomic profiling of patient cells can reveal downstream effects of transport defects.
How CRISPR Can Be Used to Study GO:0015538 sialic acid:proton symporter activity
Knockout
CRISPR-Cas9 knockout of SLC17A5 in cell lines such as HeLa or HEK293 abolishes sialic acid:proton symporter activity, leading to lysosomal sialic acid accumulation. These models are used to study the consequences of transport loss and to test rescue strategies.
Point Mutation
Introducing patient-specific point mutations (e.g., the Finnish founder mutation in SLC17A5) via CRISPR prime editing or homology-directed repair allows precise modeling of Salla disease and assessment of mutant transporter function.
Knock-in
Tagged knock-in of SLC17A5 with fluorescent or affinity tags (e.g., GFP, HA) enables live-cell imaging and biochemical purification of the transporter, facilitating studies of its trafficking and interactions.
Overexpression
Overexpression of wild-type or mutant SLC17A5 using lentiviral or plasmid vectors can rescue transport defects in patient cells or amplify signal for biochemical assays. This approach is useful for structure-function studies.
How EDITGENE Supports sialic acid:proton symporter activity Research
Researchers studying sialic acid:proton symporter activity-related genes often need to determine whether a candidate gene is causally involved in lysosomal sialic acid transport, how mutations affect transporter function, and what downstream pathways are perturbed. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for sialic acid:proton symporter activity research.
Frequently Asked Questions About sialic acid:proton symporter activity
What is sialic acid:proton symporter activity?
It is a molecular function (GO:0015538) that couples the transport of sialic acid with protons across a membrane, as defined by the Gene Ontology.
What genes are involved in sialic acid:proton symporter activity?
The primary gene is SLC17A5, which encodes Sialin, the lysosomal sialic acid transporter. Other genes such as ATP6V0A1 and TFEB regulate the proton gradient and transporter expression.
What diseases are associated with defects in sialic acid:proton symporter activity?
Mutations in SLC17A5 cause sialic acid storage diseases, including Salla disease and infantile free sialic acid storage disease, characterized by neurological impairment.
How is sialic acid:proton symporter activity measured?
It is typically measured using radioactive or fluorescent sialic acid uptake assays in isolated lysosomes or proteoliposomes, often combined with lysosomal pH measurements.
What is the role of Sialin in sialic acid transport?
Sialin (SLC17A5) is the lysosomal transporter that exports sialic acid from lysosomes into the cytoplasm using the proton gradient as an energy source.
Can CRISPR be used to study sialic acid:proton symporter activity?
Yes, CRISPR knockout, point mutation, and knock-in models of SLC17A5 are powerful tools to dissect the transport mechanism and disease pathology.
What is Salla disease?
Salla disease is a mild form of sialic acid storage disease caused by mutations in SLC17A5, leading to lysosomal accumulation of free sialic acid and progressive neurological symptoms.
How does the proton gradient drive sialic acid transport?
The V-ATPase pumps protons into lysosomes, creating a gradient that provides the energy for the symporter to move sialic acid against its concentration gradient.
Are there other transporters with sialic acid:proton symporter activity?
Sialin is the primary known transporter, but other members of the SLC17 family may exhibit similar activity, though their roles are less characterized.
What research methods are used to study sialic acid:proton symporter activity?
Common methods include transport assays, lysosomal pH measurements, immunofluorescence, co-immunoprecipitation, and CRISPR-based genetic screens.
Conclusion
Sialic acid:proton symporter activity (GO:0015538) is a fundamental molecular function required for lysosomal sialic acid homeostasis. The transporter Sialin (SLC17A5) mediates this activity, and its dysfunction leads to severe lysosomal storage diseases. Understanding the mechanism, regulation, and disease relevance of this symporter is essential for developing therapeutic strategies. EDITGENE offers comprehensive CRISPR services to facilitate research on this critical transport activity.
References
- 1. Mancini GM et al.. 1989. Characterization of a proton-driven carrier for sialic acid in the lysosomal membrane. Evidence for a group-specific transport system for acidic monosaccharides.. J Biol Chem 264(26):15247-54 PMID: 2768261
- 2. Hu W et al.. 2023. The molecular mechanism of sialic acid transport mediated by Sialin.. Sci Adv 9(3):eade8346 PMID: 36662855
- 3. Mancini GM et al.. 1991. Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides.. J Clin Invest 87(4):1329-35 PMID: 2010546
- 4. Ruivo R et al.. 2009. Molecular and cellular basis of lysosomal transmembrane protein dysfunction.. Biochim Biophys Acta 1793(4):636-49 PMID: 19146888
- 5. Havelaar AC et al.. 1998. Purification of the lysosomal sialic acid transporter. Functional characteristics of a monocarboxylate transporter.. J Biol Chem 273(51):34568-74 PMID: 9852127
- 6. Lindholm Carlström E et al.. 2019. Linkage and exome analysis implicate multiple genes in non-syndromic intellectual disability in a large Swedish family.. BMC Med Genomics 12(1):156 PMID: 31694657
- 7. Yilla M et al.. 1993. Involvement of the vacuolar H(+)-ATPases in the secretory pathway of HepG2 cells.. J Biol Chem 268(25):19092-100 PMID: 8395529
